Use the Back button in your browser to see the other results of your search or to select another record.
Beneficial effects of combined treatment with rosiglitazone and exercise on cardiovascular risk factors in patients with type 2 diabetes |
Kadoglou NP, Iliadis F, Liapis CD, Perrea D, Angelopoulou N, Alevizos M |
Diabetes Care 2007 Sep;30(9):2242-2244 |
clinical trial |
5/10 [Eligibility criteria: No; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: Yes; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed* |
This record does not have an abstract.
|